FOLLOW-UP TO THE 2011 POLITICAL DECLARATION ON HIV/AIDS: INTENSIFYING EFFORTS TO ELIMINATE HIV/AIDS | Reporting Period: January – December 2014
World Health Organization Chief Tells Security Council, Urging Sustained Focus to Prevent Future Outbreaks
The Handbook on Law and Disaster Risk Reduction (the Handbook) has been developed to provide guidance on how to use the Checklist and conduct related legislative reviews and reform processes. While the methodology for using the Checklist needs to be tailored to each country’s context and respectiv...e needs, the Handbook is intended to provide general guidance on key steps to consider.
more
The report covers possible developments in Indonesia over the next 10 months (to end 2016). Four scenarios are outlined:
Delayed Second Crop Harvest
Delayed and Reduced Second Crop Harvest
La Niña disrupts main rural sources of income
Soaring rice prices
The scenarios wer...e developed during a two-day workshop in Jakarta, Indonesia involving 21 organisations. Scenarios are a description of situations that could occur; a set of informed assumptions about a development that may require humanitarian action to support strategic planning, create awareness, provide early warning and promote preparedness activities for those responding to the crisis.
more
Agodokpessi et al. Journal of Pharmaceutical Policy and Practice (2015) 8:12DOI 10.1186/s40545-015-0033-7
Benin established a revolving drug fund (RDF) for essential asthma medicines in 2008. We evaluated
the operation of the RDF and assessed whether there was interruption of supply of asthma me...dicine from 2008 to
2013.
more
PLOS ONE | DOI:10.1371/journal.pone.0133869 July 28, 2015, p.1-16
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand...ing access to affordable antiretroviral therapy (ART).
The report is supplemented by 11 drug profiles that contain more detailed information on pricing trends and patent barriers for key antiretroviral drugs and fixed-dose combinations. Also included is an annex of conditions that define eligibility for reduced prices from 15 pharmaceutical companies.
more